OPKO Health
OPK
#6345
Rank
A$1.44 B
Marketcap
A$1.94
Share price
3.79%
Change (1 day)
-2.86%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2026 (TTM): -A$0.35 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.58 Billion. In 2025 the company made an earning of -A$0.35 Billion a decrease over its 2024 earnings that were of -A$14.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.35 Billion0.33%
2025 -A$0.35 Billion2229.09%
2024 -A$14.66 Million-94.38%
2023 -A$0.27 Billion-52.92%
2022 -A$0.56 Billion2691.58%
2021 -A$19.84 Million-128.81%
2020 A$68.85 M-115.96%
2019 -A$0.44 Billion72.03%
2018 -A$0.26 Billion-33.83%
2017 -A$0.38 Billion264.29%
2016 -A$0.11 Billion-46.71%
2015 -A$0.2 Billion-19.31%
2014 -A$0.25 Billion64.11%
2013 -A$0.15 Billion180.06%
2012 -A$52.64 Million53.56%
2011 -A$34.28 Million55.87%
2010 -A$21.99 Million-48.27%
2009 -A$42.51 Million-24.64%
2008 -A$56.4 Million-85.11%
2007 -A$0.38 Billion6.61%
2006 -A$0.36 Billion18539.02%
2005 -A$1.91 Million-32.33%
2004 -A$2.82 Million-45.53%
2003 -A$5.18 Million-64.7%
2002 -A$14.66 Million2.99%
2001 -A$14.23 Million16.9%
2000 -A$12.17 Million104.81%
1999 -A$5.95 Million40.03%
1998 -A$4.25 Million-0%
1997 -A$4.25 Million7.14%
1996 -A$3.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B-11,447.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.50 B-3,654.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.29 B-2,352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B-4,291.82%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.94 B-700.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.22 B-479.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.21 B-1,091.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-A$81.95 Million-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA